Central effects of baclofen on the L-dopa induced hyperactive urinary bladder of the rat

Naunyn Schmiedebergs Arch Pharmacol. 1985 Sep;330(3):175-8. doi: 10.1007/BF00572430.

Abstract

Cystometric recordings were performed in pentobarbitone anaesthetized rats and the effects of baclofen on urinary bladder function were evaluated as their influence on bladder hyperactivity induced by 1-dihydroxyphenylalanine (L-dopa) after peripheral decarboxylase inhibition. The bladder response was inhibited by intracerebroventricularly (i.c.v., 4th ventricle, 0.1 microgram) as well as by systemically administered (10 mg/kg i.v.) baclofen. Intravenous naloxone but not i.v. bicuculline i.c.v. substance P or i.c.v. glutamate antagonized the inhibitory actions of i.c.v. or/and i.v. baclofen. It is suggested that baclofen depresses the hyperactive bladder by a central action that is unrelated to bicuculline sensitive gamma aminobutyric acid mechanisms, substance P or glutamate neurotransmission but that is possibly related to interference with opioid mechanisms.

MeSH terms

  • Animals
  • Aromatic Amino Acid Decarboxylase Inhibitors
  • Baclofen / administration & dosage
  • Baclofen / pharmacology*
  • Bicuculline / pharmacology
  • Glutamates / pharmacology
  • Glutamic Acid
  • Injections, Intraventricular
  • Levodopa / pharmacology*
  • Male
  • Naloxone / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Substance P / pharmacology
  • Urinary Bladder / drug effects*
  • gamma-Aminobutyric Acid / physiology

Substances

  • Aromatic Amino Acid Decarboxylase Inhibitors
  • Glutamates
  • Substance P
  • Naloxone
  • Glutamic Acid
  • Levodopa
  • gamma-Aminobutyric Acid
  • Baclofen
  • Bicuculline